Study phase | Baseline 1 (screening) (month 0) | Baseline 2 (month 0) | Mid visit (month 3) | End visit (month 9) |
---|---|---|---|---|
Week | − 1 | 0 | 13 | 37 |
Visit number | 1 | 2 | 3 | 4 |
Inclusion/exclusion criteria | X | X | X | X |
Informed consent | X | |||
Medical history | X | |||
Physical examination | X | X | X | |
Exercise stress test/cardiac and vascular function | X | X | X | |
Intake 24 | X | X | X | |
Physical activity | X | X | X | |
Stool/urine sample | X | X | X | |
Fasting blood sample | X | X | X | |
Oral glucose tolerance test | X | X | X | |
Skin swab | X | X | X | |
Body composition/waist:hip | X | X | X |